Antibiotics can weaken your inherent flu defence system: Study

London: Antibiotics can leave the lung vulnerable to flu viruses, leading to significantly worse infections and symptoms, according to a study.

The research, published in the journal Cell Reports, discovered that signals from gut bacteria help to maintain a first line of defence in the lining of the lung.

When mice with healthy gut bacteria were infected with the flu, around 80 per cent of them survived. However, only a third survived if they were given antibiotics before being infected.

"We found that antibiotics can wipe out early flu resistance, adding further evidence that they should not be taken or prescribed lightly," Andreas Wack, who led the research at Francis Crick Institute in the UK.

"Inappropriate use not only promotes antibiotic resistance and kills helpful gut bacteria, but may also leave us more vulnerable to viruses. This could be relevant not only in humans but also livestock animals, as many farms around the world use antibiotics prophylactically," Wack said.

The study found that type I interferon signalling, which is known to regulate immune responses, was key to early defence.

Among the genes switched on by interferon is a mouse gene, Mx1, which is the equivalent of the human MxA gene. This antiviral gene produces proteins that can interfere with influenza virus replication.

Although often studied in immune cells, researchers found that microbiota-driven interferon signals also keep antiviral genes in the lung lining active, preventing the virus from gaining a foothold.

"We were surprised to discover that the cells lining the lung, rather than immune cells, were responsible for early flu resistance induced by microbiota," Wack said.

"Previous studies have focused on immune cells, but we found that the lining cells are more important for the crucial early stages of infection," he said.

"They are the only place that the virus can multiply, so they are the key battleground in the fight against flu. Gut bacteria send a signal that keeps the cells lining the lung prepared, preventing the virus from multiplying so quickly," he added.

To test whether the protective effect was related to gut bacteria rather than local processes in the lung, the researchers treated mice with antibiotics and then repopulated their gut bacteria through faecal transplant.

This restored interferon signalling and associated flu resistance, suggesting that gut bacteria play a crucial role in maintaining defences.

"Taken together, our findings show that gut bacteria help to keep non-immune cells elsewhere in the body prepared for attack," Wack said.

"They are better protected from flu because antiviral genes are already switched on when the virus arrives. So when the virus infects a prepared organism, it has almost lost before the battle starts," he said.

"By contrast, without gut bacteria, the antiviral genes won't come on until the immune response kicks in. This is sometimes too late as the virus has already multiplied many times, so a massive, damaging immune response is inevitable," he added.